1. Home
  2. LSTA vs BEEM Comparison

LSTA vs BEEM Comparison

Compare LSTA & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • BEEM
  • Stock Information
  • Founded
  • LSTA 1980
  • BEEM 2006
  • Country
  • LSTA United States
  • BEEM United States
  • Employees
  • LSTA N/A
  • BEEM N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • BEEM Semiconductors
  • Sector
  • LSTA Health Care
  • BEEM Technology
  • Exchange
  • LSTA Nasdaq
  • BEEM Nasdaq
  • Market Cap
  • LSTA 20.0M
  • BEEM 22.3M
  • IPO Year
  • LSTA N/A
  • BEEM N/A
  • Fundamental
  • Price
  • LSTA $2.39
  • BEEM $1.39
  • Analyst Decision
  • LSTA Strong Buy
  • BEEM Strong Buy
  • Analyst Count
  • LSTA 1
  • BEEM 4
  • Target Price
  • LSTA $15.00
  • BEEM $9.00
  • AVG Volume (30 Days)
  • LSTA 13.3K
  • BEEM 193.6K
  • Earning Date
  • LSTA 05-08-2025
  • BEEM 04-11-2025
  • Dividend Yield
  • LSTA N/A
  • BEEM N/A
  • EPS Growth
  • LSTA N/A
  • BEEM N/A
  • EPS
  • LSTA N/A
  • BEEM N/A
  • Revenue
  • LSTA $1,000,000.00
  • BEEM $49,336,000.00
  • Revenue This Year
  • LSTA N/A
  • BEEM $27.41
  • Revenue Next Year
  • LSTA N/A
  • BEEM $58.00
  • P/E Ratio
  • LSTA N/A
  • BEEM N/A
  • Revenue Growth
  • LSTA N/A
  • BEEM N/A
  • 52 Week Low
  • LSTA $1.87
  • BEEM $1.33
  • 52 Week High
  • LSTA $4.20
  • BEEM $7.68
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 60.67
  • BEEM 30.42
  • Support Level
  • LSTA $1.91
  • BEEM $1.33
  • Resistance Level
  • LSTA $2.09
  • BEEM $1.48
  • Average True Range (ATR)
  • LSTA 0.18
  • BEEM 0.19
  • MACD
  • LSTA 0.06
  • BEEM -0.02
  • Stochastic Oscillator
  • LSTA 100.00
  • BEEM 7.50

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

Share on Social Networks: